AstraZeneca to Transfer Some Global Drug Rights to Covis Pharma
On Monday, 1st November 2021, AstraZeneca said, it is going to be transferring the global rights for the respiratory medicines including Duaklir and Eklira to the Covis Pharma Group for a deal of 270 million dollars as AstraZeneca is looking to offload the company’s old portfolio of the medicines. The company ‘AstraZeneca’ also said, under […]
Continue Reading